Thyroid cancer is a disease in which malignant (cancer) cells form in the tissues of the thyroid gland. In 2020, there were ...

In 2023, research on mice and rats suggested semaglutide — the powerful ingredient behind Wegovy and Ozempic — could raise ...

More thyroid cancers were detected soon after starting a GLP-1 receptor agonist than other diabetes drugs, a secondary ...

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...

Thyroid cancer is occasionally associated with hyperthyroidism. Papillary thyroid carcinoma is the most frequently reported histologic type followed by follicular thyroid carcinoma. Medullary ...

Everything you need to know about thyroid cancer, from early warning signs to treatment options. Doctors reveal crucial ...

Tests commonly ordered check levels of thyroid-stimulating hormone (TSH) and T3 and T4 hormones. Blood tests are also used to monitor thyroid cancers. Medullary thyroid cancer accounts for around 5% ...

After extensive surgery, calcitonin levels plummet in most patients with medullary thyroid carcinoma (MTC) without lymph node metastases. Calcitonin, however, remains elevated in two-thirds of ...

3. Oncocytic Carcinoma: less common (3%), more difficult to find and cure. 4. Medullary Thyroid Cancer (MTC) develops from C cells, generates calcitonin, and has the potential to spread before ...

program were used to calculate annual age-adjusted incidence and mortality rates for thyroid cancer (categorized as papillary, follicular, medullary, or anaplastic). Between 1973 and 2002 ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.